From our beginning, corporate partnerships have provided significant funding to Cure EB, and have contributed significantly to accelerate epidermolysis bullosa research. For example, a very significant donation from Goldman Sachs Gives enabled the EBSTEM trial to start, which would otherwise been significantly delayed.
At Cure EB we understand your corporate responsibility needs. Our engagement with companies ranges from high level partnerships to supporting employee fundraising activities. We strive to build truly tailored and mutually beneficial partnerships to ensure that you achieve your philanthropic agenda as well as helping to cure EB.
We would like to give our most heartfelt thanks to:
If you’d be interested in a partnership, or if you’d like to learn more about Cure EB, please do get in touch.